Drug Type Small molecule drug |
Synonyms S06593, Triplixam |
Target |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers), Symporters inhibitors |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H25ClN2O5 |
InChIKeyHTIQEAQVCYTUBX-UHFFFAOYSA-N |
CAS Registry88150-42-9 |